Cymbalta gets Mixed Reception
Thursday August 26, 2004
Eli Lilly's new antidepressant Cymbalta should be hitting the streets in the U.S. any day now. The company hopes that it has found a money-maker, since It's flagship antidepressant Prozac is now available in a cheaper generic version.
Cymbalta (duloxetine) is one of a new class of antidepressants that targets both serotonin and norepinephrine. It's also the drug that a college student was taking when she hanged herself in a Lilly research facility.
Read more about Cymbalta
Cymbalta (duloxetine) is one of a new class of antidepressants that targets both serotonin and norepinephrine. It's also the drug that a college student was taking when she hanged herself in a Lilly research facility.
Read more about Cymbalta